The FDA needs to set standards for using artificial intelligence in drug development
Charles K. Fisher
November 7, 2019
Opinion: Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet appropriate standards.